{"recordsFiltered":50008,"recordsTotal":50008,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=46800","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=46200","results":[{"registry_id":"NCT06680752","publication_url":"https://clinicaltrials.gov/study/NCT06680752","title":"A Phase 1/2, Open-label, Multicenter Trial to Assess the Safety and Efficacy of ARD103 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome","has_exemption":false,"start_date":"2025-05-20","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"ARCE Therapeutics, Inc.","sponsor_slug":"arce-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06693011","publication_url":"https://clinicaltrials.gov/study/NCT06693011","title":"Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial","has_exemption":false,"start_date":"2025-06-10","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Cerus Endovascular, Inc.","sponsor_slug":"cerus-endovascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06328608","publication_url":"https://clinicaltrials.gov/study/NCT06328608","title":"Multi-centre, Open-label Trial to Assess the saFety, Pharmacodynamics, Efficacy and Pharmacokinetics of pegunigaLsidase Alfa in Patients From 2 Years to Less Than 18 Years of Age With Confirmed FabrY Disease","has_exemption":false,"start_date":"2025-07-29","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Chiesi Farmaceutici S.p.A.","sponsor_slug":"chiesi-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06854159","publication_url":"https://clinicaltrials.gov/study/NCT06854159","title":"A Phase 2 Study of Odronextamab in Relapsed/ Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Before and After Chimeric Antigen Receptor (CAR) T-Cell Therapy","has_exemption":false,"start_date":"2025-08-07","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07416149","publication_url":"https://clinicaltrials.gov/study/NCT07416149","title":"Reducing Post-operative Hypoparathyroidism With Probe-based Near Infrared Autofluorescence (NIRAF)- Assisted Total Thyroidectomy Versus Conventional Total Thyroidectomy, a Randomized-controlled Trial","has_exemption":false,"start_date":"2025-09-16","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224256","publication_url":"https://clinicaltrials.gov/study/NCT07224256","title":"VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration","has_exemption":false,"start_date":"2025-10-03","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Neuralink Corp","sponsor_slug":"neuralink-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06330493","publication_url":"https://clinicaltrials.gov/study/NCT06330493","title":"Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of AcoArt Litos Paclitaxel Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Versus Non-Coated Standard Balloon Angioplasty for the Treatment of Infrapopliteal Obstructions in Patients With Chronic Limb-Threatening Ischemia","has_exemption":false,"start_date":"2025-10-10","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Acotec Scientific Co., Ltd","sponsor_slug":"acotec-scientific-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06784336","publication_url":"https://clinicaltrials.gov/study/NCT06784336","title":"Phase II Multi-center Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation","has_exemption":false,"start_date":"2025-10-15","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07115004","publication_url":"https://clinicaltrials.gov/study/NCT07115004","title":"A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)","has_exemption":false,"start_date":"2025-10-15","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Vega Therapeutics, Inc","sponsor_slug":"vega-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07045194","publication_url":"https://clinicaltrials.gov/study/NCT07045194","title":"A Prospective, Multi-center, Single-blind, Randomized (1:1), Non-inferiority Study Comparing Clinical Outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the Treatment of Coronary Artery In-stent Restenosis (ISR).","has_exemption":false,"start_date":"2025-10-20","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Orchestra BioMed, Inc","sponsor_slug":"orchestra-biomed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07194850","publication_url":"https://clinicaltrials.gov/study/NCT07194850","title":"A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants From 12 Years to Less Than 18 Years of Age With Chronic ITP","has_exemption":false,"start_date":"2025-10-20","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223021","publication_url":"https://clinicaltrials.gov/study/NCT07223021","title":"Improving EveNt Free Survival by Optimizing FLUdarabine Exposure During LymphodepletioN for CAR T CEll Therapy: a Randomized, Multi-center Study of Children and Young Adults With B-cell Acute Lymphoblastic Leukemia (INFLUENCE)","has_exemption":false,"start_date":"2025-10-20","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06878560","publication_url":"https://clinicaltrials.gov/study/NCT06878560","title":"EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD)","has_exemption":false,"start_date":"2025-10-29","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225751","publication_url":"https://clinicaltrials.gov/study/NCT07225751","title":"A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions","has_exemption":false,"start_date":"2025-11-25","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Kuros Biosurgery AG","sponsor_slug":"kuros-biosurgery-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07357415","publication_url":"https://clinicaltrials.gov/study/NCT07357415","title":"A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial","has_exemption":false,"start_date":"2026-01-24","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07389590","publication_url":"https://clinicaltrials.gov/study/NCT07389590","title":"A Pilot Study of Ublituximab in People With MS Experiencing Wearing Off Phenomena While Receiving Treatment With Ocrelizumab","has_exemption":false,"start_date":"2026-02-10","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510309","publication_url":"https://clinicaltrials.gov/study/NCT06510309","title":"A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma","has_exemption":false,"start_date":"2026-02-11","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Gottfried von Keudell, MD PhD","sponsor_slug":"gottfried-von-keudell-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07368998","publication_url":"https://clinicaltrials.gov/study/NCT07368998","title":"A Phase II, Randomized, Open-Label Study Evaluating Two Inavolisib Dose Levels in Combination With Fulvestrant in Participants With PIK3CA-Mutated, HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2026-02-18","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07291297","publication_url":"https://clinicaltrials.gov/study/NCT07291297","title":"Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma","has_exemption":false,"start_date":"2026-03-04","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07062354","publication_url":"https://clinicaltrials.gov/study/NCT07062354","title":"A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer","has_exemption":false,"start_date":"2026-03-25","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225270","publication_url":"https://clinicaltrials.gov/study/NCT07225270","title":"A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum-Sensitive Ovarian Cancer (PSOC)","has_exemption":false,"start_date":"2026-04-03","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06891885","publication_url":"https://clinicaltrials.gov/study/NCT06891885","title":"A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Sheets (DSP-3077) in Adults With Retinitis Pigmentosa (RP)","has_exemption":false,"start_date":"2026-04-16","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Sumitomo Pharma America, Inc.","sponsor_slug":"sumitomo-pharma-america-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07602036","publication_url":"https://clinicaltrials.gov/study/NCT07602036","title":"Type 2 Diabetes and Pregnancy a Single-arm Interventional Study","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Poznan University of Medical Sciences","sponsor_slug":"poznan-university-of-medical-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07555938","publication_url":"https://clinicaltrials.gov/study/NCT07555938","title":"A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Patients With Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy","has_exemption":false,"start_date":"2026-06-23","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619482","publication_url":"https://clinicaltrials.gov/study/NCT07619482","title":"A Phase 1/2 Dose Escalation Followed by a Masked, Randomized, Placebo-Controlled Study to Evaluate Topical Insulin for Neuroprotection in Open Angle Glaucoma","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205589","publication_url":"https://clinicaltrials.gov/study/NCT06205589","title":"A Phase 2a/2b Study Evaluating Safety, Immunogenicity, and Therapeutic Efficacy of ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB","has_exemption":false,"start_date":"2026-07-01","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","sponsor_slug":"advancing-clinical-therapeutics-globally-for-hivaids-and-other-infections","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566364","publication_url":"https://clinicaltrials.gov/study/NCT07566364","title":"A Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive Measurable Residual Disease","has_exemption":false,"start_date":"2026-07-09","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05882344","publication_url":"https://clinicaltrials.gov/study/NCT05882344","title":"Cholinergic Deep Brain Stimulation for Alzheimer's Disease","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290777","publication_url":"https://clinicaltrials.gov/study/NCT07290777","title":"A Phase 2, Randomized, Partially Blinded, Controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of VEL-101 in Kidney Transplant Recipients.","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Veloxis Pharmaceuticals","sponsor_slug":"veloxis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07705555","publication_url":"https://clinicaltrials.gov/study/NCT07705555","title":"A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)","has_exemption":false,"start_date":"2026-08-28","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135687","publication_url":"https://clinicaltrials.gov/study/NCT07135687","title":"Oral Losartan to Decrease the Risk of Postoperative Arthrofibrosis Following Primary and Revision Anterior Cruciate Ligament Reconstruction","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07680439","publication_url":"https://clinicaltrials.gov/study/NCT07680439","title":"A Phase 2 Pivotal Study of BCB-276, a B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"BrainChild Bio, Inc","sponsor_slug":"brainchild-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07742735","publication_url":"https://clinicaltrials.gov/study/NCT07742735","title":"A Parallel-group Treatment, Phase 3, Double-blind, Randomized, 2-arm Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"VectivBio AG","sponsor_slug":"vectivbio-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07745374","publication_url":"https://clinicaltrials.gov/study/NCT07745374","title":"Deep Brain Stimulation for Bipolar Depression: Assessing the Safety and Use of Intracranial Neurophenotyping of State Switches","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07766018","publication_url":"https://clinicaltrials.gov/study/NCT07766018","title":"A Phase 2 Open-Label, Single-Arm, Multicenter Trial to Evaluate the Efficacy and Safety of Elacestrant Monotherapy for the Treatment of Japanese Participants With ER+/HER2- Advanced or Metastatic Breast Cancer With ESR1-mutation Following CDK4/6 Inhibitor Therapy","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Stemline Therapeutics, Inc.","sponsor_slug":"stemline-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07713199","publication_url":"https://clinicaltrials.gov/study/NCT07713199","title":"Free Soft Tissue Grafts (FSTG) Using Autograft Palatal Donor Tissue vs. Xenograft Collagen Soft Tissue Matrix From Porcine Achilles Tendon (Zderm™)","has_exemption":false,"start_date":"2026-09-15","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05855694","publication_url":"https://clinicaltrials.gov/study/NCT05855694","title":"Pilot Study of Photobiomodulation for Cancer-Related Cognitive Impairment","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Arash Asher, MD","sponsor_slug":"arash-asher-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06272201","publication_url":"https://clinicaltrials.gov/study/NCT06272201","title":"Incisionless Suture Plications in a POSE2.0 Interventional Randomized Obesity Study (The INSPIRO Study)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"USGI Medical","sponsor_slug":"usgi-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06675435","publication_url":"https://clinicaltrials.gov/study/NCT06675435","title":"The Effect of Inhaled Nitric Oxide on Intrapulmonary Shunt in Acutely Hypoxemic Patients With Severe Obesity","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224711","publication_url":"https://clinicaltrials.gov/study/NCT07224711","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (IMPALA ERAS)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07678242","publication_url":"https://clinicaltrials.gov/study/NCT07678242","title":"The Lucida Project","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07738510","publication_url":"https://clinicaltrials.gov/study/NCT07738510","title":"A Phase 2b, Multicenter, Open-label, Randomized, Dose Optimization Study of Ofirnoflast (HT-6184) for the Treatment of Anemia in Adults With Very Low- to Intermediate-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Halia Therapeutics, Inc.","sponsor_slug":"halia-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07755904","publication_url":"https://clinicaltrials.gov/study/NCT07755904","title":"A Phase 3, Multi-region, Multi-center, Randomized, Double-blind, Active-Comparator-Controlled Trial to Evaluate the Efficacy and Safety of BHB-1893 Compared to Metoprolol in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Braveheart Bio, Inc.","sponsor_slug":"braveheart-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07728214","publication_url":"https://clinicaltrials.gov/study/NCT07728214","title":"Reminder-enhanced Incentive Spirometry Evaluation (RISE)","has_exemption":false,"start_date":"2026-11-01","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06916325","publication_url":"https://clinicaltrials.gov/study/NCT06916325","title":"DeLIVER Trial: A Prospective, Multi-Center, Single-Arm, Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion","has_exemption":false,"start_date":"2027-01-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"XVIVO Perfusion","sponsor_slug":"xvivo-perfusion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224698","publication_url":"https://clinicaltrials.gov/study/NCT07224698","title":"Phase 2 Multicenter Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of Inhaled Cannabis in Veterans for Treatment of Posttraumatic Stress Disorder (PTSD)","has_exemption":false,"start_date":"2027-02-28","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Multidisciplinary Association for Psychedelic Studies","sponsor_slug":"multidisciplinary-association-for-psychedelic-studies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04266275","publication_url":"https://clinicaltrials.gov/study/NCT04266275","title":"An Investigation in the Use of Curcumin Topical Herbal Agent for the Treatment of Cervical Intraepithelial Neoplasia","has_exemption":false,"start_date":"2027-04-30","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Lisa Flowers","sponsor_slug":"lisa-flowers","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05276011","publication_url":"https://clinicaltrials.gov/study/NCT05276011","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Determine the Efficacy, Safety, and Dosing of TG-C in Adult Subjects With Symptomatic Early Hip Osteoarthritis","has_exemption":false,"start_date":"2027-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Kolon TissueGene, Inc.","sponsor_slug":"kolon-tissuegene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04893109","publication_url":"https://clinicaltrials.gov/study/NCT04893109","title":"A Randomized Phase II Trial of Adjuvant Trastuzumab Emtansine (T-DM1) Followed by Subcutaneous Trastuzumab Versus Paclitaxel in Combination With Subcutaneous Trastuzumab for Stage I HER2-positive Breast Cancer (ATEMPT 2.0)","has_exemption":false,"start_date":"2021-06-16","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05517655","publication_url":"https://clinicaltrials.gov/study/NCT05517655","title":"BEGIN Novel ImagiNG Biomarkers","has_exemption":false,"start_date":"2022-05-01","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03934905","publication_url":"https://clinicaltrials.gov/study/NCT03934905","title":"Phase II Trial of Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction (CRI18-026)","has_exemption":false,"start_date":"2022-06-01","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Texas Tech University Health Sciences Center","sponsor_slug":"texas-tech-university-health-sciences-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06080503","publication_url":"https://clinicaltrials.gov/study/NCT06080503","title":"G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy","has_exemption":false,"start_date":"2024-03-14","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06709495","publication_url":"https://clinicaltrials.gov/study/NCT06709495","title":"Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas","has_exemption":false,"start_date":"2025-01-27","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"David S Shulman, MD","sponsor_slug":"david-s-shulman-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06819007","publication_url":"https://clinicaltrials.gov/study/NCT06819007","title":"A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112/APGOT-OV13)","has_exemption":false,"start_date":"2025-03-19","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973629","publication_url":"https://clinicaltrials.gov/study/NCT06973629","title":"A Two-Part Phase 3b Randomized, Double-Blind, Placebo-Controlled, Followed by Open-Label Extension, Multicenter Study of the Efficacy and Safety of MSC-NTF (NurOwn) in Participants With With Early Symptomatic and Moderate Disease Presentation in Amyotrophic Lateral Sclerosis (ALS)","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Brainstorm-Cell Therapeutics","sponsor_slug":"brainstorm-cell-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217301","publication_url":"https://clinicaltrials.gov/study/NCT07217301","title":"A Randomized, Open Label, Multicenter, Phase 3 Trial Evaluating the Efficacy and Safety of TAK-928 Versus Docetaxel in Participants With Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Disease Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy","has_exemption":false,"start_date":"2025-11-26","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07283731","publication_url":"https://clinicaltrials.gov/study/NCT07283731","title":"Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma","has_exemption":false,"start_date":"2026-04-14","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07126561","publication_url":"https://clinicaltrials.gov/study/NCT07126561","title":"Phase II Open Label Trial of Trastuzumab Deruxtecan (Enhertu, DS-8210) in HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2","has_exemption":false,"start_date":"2026-11-01","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07538336","publication_url":"https://clinicaltrials.gov/study/NCT07538336","title":"Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction","has_exemption":false,"start_date":"2026-11-02","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06152237","publication_url":"https://clinicaltrials.gov/study/NCT06152237","title":"A Multicenter, Open Label, Randomized, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females With Rett Syndrome","has_exemption":false,"start_date":"2023-12-12","completion_date":"2028-11-02","has_results":false,"results_due":false,"sponsor_name":"Taysha Gene Therapies, Inc.","sponsor_slug":"taysha-gene-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06750289","publication_url":"https://clinicaltrials.gov/study/NCT06750289","title":"BRISOTE: A Multicentre, Randomised, Double-Blind, Parallel Group, Active-Controlled, Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose Inhaled Corticosteroid Plus Long-acting β2-Agonist.","has_exemption":false,"start_date":"2025-03-28","completion_date":"2028-11-03","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011745","publication_url":"https://clinicaltrials.gov/study/NCT07011745","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)","has_exemption":false,"start_date":"2025-07-16","completion_date":"2028-11-03","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06189313","publication_url":"https://clinicaltrials.gov/study/NCT06189313","title":"A Prospective, Multicenter Study to Evaluate the Safety and Efficacy of an Aspiration Thrombectomy System in Acute Pulmonary Embolism","has_exemption":false,"start_date":"2025-01-03","completion_date":"2028-11-04","has_results":false,"results_due":false,"sponsor_name":"Argon Medical Devices","sponsor_slug":"argon-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07160244","publication_url":"https://clinicaltrials.gov/study/NCT07160244","title":"A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS","has_exemption":false,"start_date":"2025-08-25","completion_date":"2028-11-06","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07772531","publication_url":"https://clinicaltrials.gov/study/NCT07772531","title":"A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of BMS-986511 in Two Sequential Parts in Participants With Major Depressive Disorder","has_exemption":false,"start_date":"2026-10-30","completion_date":"2028-11-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06504394","publication_url":"https://clinicaltrials.gov/study/NCT06504394","title":"A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)","has_exemption":false,"start_date":"2024-10-14","completion_date":"2028-11-08","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04375800","publication_url":"https://clinicaltrials.gov/study/NCT04375800","title":"A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Participants With HIV-1, Who Are 4 Weeks to Less Than 12 Years of Age and Weigh Less Than 45 kg","has_exemption":false,"start_date":"2021-02-03","completion_date":"2028-11-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161519","publication_url":"https://clinicaltrials.gov/study/NCT06161519","title":"Phase I/II Trial of PLX038 in Primary Central Nervous System Tumors With and Without MYC or MYCN Amplifications","has_exemption":false,"start_date":"2024-01-31","completion_date":"2028-11-14","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301034","publication_url":"https://clinicaltrials.gov/study/NCT07301034","title":"Effects of Ziltivekimab Versus Placebo on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction. A Serial, Multivessel, Intravascular Ultrasound, Near-infrared Spectroscopy and Optical Coherence Tomography Imaging Study","has_exemption":false,"start_date":"2025-12-18","completion_date":"2028-11-14","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07335562","publication_url":"https://clinicaltrials.gov/study/NCT07335562","title":"A Phase 3, Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of BMS-986353, CD19-targeted NEX-T CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (Breakfree-SSc)","has_exemption":false,"start_date":"2026-08-29","completion_date":"2028-11-14","has_results":false,"results_due":false,"sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","sponsor_slug":"juno-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04626024","publication_url":"https://clinicaltrials.gov/study/NCT04626024","title":"Safety And Efficacy Of Tyrosine Kinase Inhibitor Cessation For Chronic Myeloid Leukemia Patients With Stable Molecular Response In A Real World Population","has_exemption":false,"start_date":"2020-12-22","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05051033","publication_url":"https://clinicaltrials.gov/study/NCT05051033","title":"Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)","has_exemption":false,"start_date":"2022-02-21","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Annetine Gelijns","sponsor_slug":"annetine-gelijns","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06144606","publication_url":"https://clinicaltrials.gov/study/NCT06144606","title":"Phase 2 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)","has_exemption":false,"start_date":"2023-12-26","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06571383","publication_url":"https://clinicaltrials.gov/study/NCT06571383","title":"Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly","has_exemption":false,"start_date":"2024-09-17","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847542","publication_url":"https://clinicaltrials.gov/study/NCT06847542","title":"A Phase IIIb, Multicenter, Single-arm Study Assessing the Effectiveness, Safety and Patient Reported Outcomes of a 36-week Refill Exchange Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2025-11-27","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092527","publication_url":"https://clinicaltrials.gov/study/NCT07092527","title":"Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version","has_exemption":false,"start_date":"2025-12-05","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214779","publication_url":"https://clinicaltrials.gov/study/NCT07214779","title":"A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression","has_exemption":false,"start_date":"2025-12-09","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05490277","publication_url":"https://clinicaltrials.gov/study/NCT05490277","title":"Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke","has_exemption":false,"start_date":"2026-01-15","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07411599","publication_url":"https://clinicaltrials.gov/study/NCT07411599","title":"Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial (\"Chip-CRC Trial\")","has_exemption":false,"start_date":"2026-04-20","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07499232","publication_url":"https://clinicaltrials.gov/study/NCT07499232","title":"A Phase 3b, Multicenter, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy and Safety of Guselkumab Versus Risankizumab in the Treatment of Participants With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-04-21","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06097728","publication_url":"https://clinicaltrials.gov/study/NCT06097728","title":"A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma (eVOLVE-Meso)","has_exemption":false,"start_date":"2023-11-09","completion_date":"2028-11-16","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218809","publication_url":"https://clinicaltrials.gov/study/NCT07218809","title":"A Randomised, Open-label, Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine in FRα-high and AZD5335 Versus Investigator's Choice Chemotherapy in FRα-low Expressing High-grade Platinum-resistant Epithelial Ovarian Cancer Patients (TREVI-OC-01)","has_exemption":false,"start_date":"2025-12-29","completion_date":"2028-11-17","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07709546","publication_url":"https://clinicaltrials.gov/study/NCT07709546","title":"The Prophylactic Effect of Closed Incision Negative Pressure Therapy on Vascular Entry Site Complications Following ECMO Decannulation","has_exemption":false,"start_date":"2026-07-13","completion_date":"2028-11-18","has_results":false,"results_due":false,"sponsor_name":"St. Antonius Hospital","sponsor_slug":"st-antonius-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858735","publication_url":"https://clinicaltrials.gov/study/NCT06858735","title":"HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma","has_exemption":false,"start_date":"2025-06-10","completion_date":"2028-11-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07252050","publication_url":"https://clinicaltrials.gov/study/NCT07252050","title":"Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2026-06-08","completion_date":"2028-11-19","has_results":false,"results_due":false,"sponsor_name":"Arkansas Children's Hospital Research Institute","sponsor_slug":"arkansas-childrens-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06112379","publication_url":"https://clinicaltrials.gov/study/NCT06112379","title":"A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients With Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)","has_exemption":false,"start_date":"2023-11-14","completion_date":"2028-11-20","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07430592","publication_url":"https://clinicaltrials.gov/study/NCT07430592","title":"A Phase 2B Trial of the Combination of SJ733 and Tafenoquine for Radical Cure of P. Vivax Malaria in Comparison to Chloroquine-Tafenoquine","has_exemption":false,"start_date":"2026-10-01","completion_date":"2028-11-20","has_results":false,"results_due":false,"sponsor_name":"R. Kiplin Guy","sponsor_slug":"r-kiplin-guy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07775924","publication_url":"https://clinicaltrials.gov/study/NCT07775924","title":"A Phase IIb Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-range Study to Assess the Efficacy and Safety of GIA632 in Participants With Moderate to Severe Cutaneous Lichen Planus, Followed by an Extension Period","has_exemption":false,"start_date":"2026-09-10","completion_date":"2028-11-22","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011732","publication_url":"https://clinicaltrials.gov/study/NCT07011732","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease","has_exemption":false,"start_date":"2025-07-10","completion_date":"2028-11-24","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07257055","publication_url":"https://clinicaltrials.gov/study/NCT07257055","title":"Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-11-24","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06947993","publication_url":"https://clinicaltrials.gov/study/NCT06947993","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Platform Study to Assess the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-05-16","completion_date":"2028-11-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06184152","publication_url":"https://clinicaltrials.gov/study/NCT06184152","title":"Contrast Ultrasound vs. Abbreviated MRI for Detection of HCC in Patients With Indeterminate Liver Nodules","has_exemption":false,"start_date":"2023-11-28","completion_date":"2028-11-28","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321574","publication_url":"https://clinicaltrials.gov/study/NCT07321574","title":"An Open-Label, Multi-Cohort Phase IIb Clinical Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-11-28","has_results":false,"results_due":false,"sponsor_name":"Shanghai AB PharmaTech Ltd.","sponsor_slug":"shanghai-ab-pharmatech-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221669","publication_url":"https://clinicaltrials.gov/study/NCT07221669","title":"An Open-Label Study to Assess the Efficacy and Safety of Multiple Doses of Salanersen (BIIB115) Delivered Intrathecally to Treatment-Naïve, Presymptomatic Infants With Genetically Diagnosed Spinal Muscular Atrophy","has_exemption":false,"start_date":"2026-04-28","completion_date":"2028-11-28","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06649110","publication_url":"https://clinicaltrials.gov/study/NCT06649110","title":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)","has_exemption":false,"start_date":"2024-10-24","completion_date":"2028-11-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07024563","publication_url":"https://clinicaltrials.gov/study/NCT07024563","title":"A Phase 3, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Ravulizumab in Pediatric Participants (2 to < 18 Years of Age) With Primary Immunoglobulin A Nephropathy (IgAN)","has_exemption":false,"start_date":"2025-06-14","completion_date":"2028-11-29","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00682318","publication_url":"https://clinicaltrials.gov/study/NCT00682318","title":"Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers: a Randomized Double-blinded Trial on the Modulation of the Eicosanoid and Isoprostane Pathways in Healthy Subjects by Omega-3 Polyunsaturated Fatty Acids and Red Wine.","has_exemption":false,"start_date":"2008-05-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Carsten Skarke, MD","sponsor_slug":"carsten-skarke-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03301506","publication_url":"https://clinicaltrials.gov/study/NCT03301506","title":"ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)","has_exemption":false,"start_date":"2017-12-12","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03833921","publication_url":"https://clinicaltrials.gov/study/NCT03833921","title":"Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity, PSA Decline and Genetic Variation in Proteins Involved in Androgen Metabolism in Metastatic Hormone Naive Prostate Cancer","has_exemption":false,"start_date":"2019-05-23","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Martha Mims","sponsor_slug":"martha-mims","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04781972","publication_url":"https://clinicaltrials.gov/study/NCT04781972","title":"Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD","has_exemption":false,"start_date":"2021-07-27","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05079841","publication_url":"https://clinicaltrials.gov/study/NCT05079841","title":"The Stimulation To Induce Mothers (STIM) Study: A Parallel Group Randomized Controlled Trial","has_exemption":false,"start_date":"2021-11-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05228145","publication_url":"https://clinicaltrials.gov/study/NCT05228145","title":"A Phase 1/2 Intracerebroventricular and Intravitreal Administration of NGN-101 for Treatment of Neuronal Ceroid Lipofuscinosis (NCL) Subtype 5 (CLN5) Disease","has_exemption":false,"start_date":"2022-01-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Neurogene Inc.","sponsor_slug":"neurogene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05076617","publication_url":"https://clinicaltrials.gov/study/NCT05076617","title":"An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures","has_exemption":false,"start_date":"2022-02-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05121376","publication_url":"https://clinicaltrials.gov/study/NCT05121376","title":"A Phase 1/2 Open-Label, Dose-Escalation Study to Determine the Safety Tolerability & Efficacy of BMN 331 an AAV Vector-Mediated Gene Transfer of Human SERPING1 Gene in Subjects With HAE Due to Human C1-INH Deficiency","has_exemption":false,"start_date":"2022-02-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05281731","publication_url":"https://clinicaltrials.gov/study/NCT05281731","title":"Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma","has_exemption":false,"start_date":"2022-04-18","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05194111","publication_url":"https://clinicaltrials.gov/study/NCT05194111","title":"Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (Treat HF)","has_exemption":false,"start_date":"2022-08-11","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05278208","publication_url":"https://clinicaltrials.gov/study/NCT05278208","title":"Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET","has_exemption":false,"start_date":"2022-11-21","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669989","publication_url":"https://clinicaltrials.gov/study/NCT05669989","title":"International, Multi-center, Open-label, Treatment Extension Study in Patients With Multiple Myeloma Who Are Still Benefitting From Isatuximab-based Therapy Following Completion of a Phase 1, 2, or 3 Parental Study","has_exemption":false,"start_date":"2023-04-05","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796375","publication_url":"https://clinicaltrials.gov/study/NCT05796375","title":"Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance","has_exemption":false,"start_date":"2023-11-17","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"White River Junction Veterans Affairs Medical Center","sponsor_slug":"white-river-junction-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06157528","publication_url":"https://clinicaltrials.gov/study/NCT06157528","title":"Diagnosis of Pelvic Endometriosis: a Preliminary Study on the Added Value of R2*MFGRE Sequence in MRI","has_exemption":false,"start_date":"2023-12-20","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Zhenshen Ma","sponsor_slug":"zhenshen-ma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06169852","publication_url":"https://clinicaltrials.gov/study/NCT06169852","title":"Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD","has_exemption":false,"start_date":"2024-01-12","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06075953","publication_url":"https://clinicaltrials.gov/study/NCT06075953","title":"DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study","has_exemption":false,"start_date":"2024-02-17","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"QuantumLeap Healthcare Collaborative","sponsor_slug":"quantumleap-healthcare-collaborative","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05940324","publication_url":"https://clinicaltrials.gov/study/NCT05940324","title":"Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)","has_exemption":false,"start_date":"2024-02-24","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06316297","publication_url":"https://clinicaltrials.gov/study/NCT06316297","title":"A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age","has_exemption":false,"start_date":"2024-04-05","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06295159","publication_url":"https://clinicaltrials.gov/study/NCT06295159","title":"Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma","has_exemption":false,"start_date":"2024-05-17","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284122","publication_url":"https://clinicaltrials.gov/study/NCT06284122","title":"A Phase III Randomized, Open-label, International, Multicenter Study Evaluating the Efficacy and Safety of Mosunetuzumab Plus Lenalidomide in Comparison to Anti-CD20 Monoclonal Antibody Plus Chemotherapy in Subjects With Previously Untreated FLIPI 2-5 Follicular Lymphoma","has_exemption":false,"start_date":"2024-06-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"The Lymphoma Academic Research Organisation","sponsor_slug":"the-lymphoma-academic-research-organisation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05869682","publication_url":"https://clinicaltrials.gov/study/NCT05869682","title":"Phase 2 Study of Bright White Light During Treatment With ADT Combination Therapy in Men With Advanced Prostate Cancer to PreServe PHysIcal and MeNtal HEalth (SHINE)","has_exemption":false,"start_date":"2024-07-09","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06535607","publication_url":"https://clinicaltrials.gov/study/NCT06535607","title":"A Phase II, Multi-Center Study to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination With Anti-cancer Agents in Participants With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2024-08-22","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467305","publication_url":"https://clinicaltrials.gov/study/NCT06467305","title":"Sensorimotor Basis of Speech Motor Learning and Retention","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06491823","publication_url":"https://clinicaltrials.gov/study/NCT06491823","title":"Sensorimotor Basis of Speech Motor Learning and Retention","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467292","publication_url":"https://clinicaltrials.gov/study/NCT06467292","title":"Sensorimotor Basis of Speech Motor Learning and Retention","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06581432","publication_url":"https://clinicaltrials.gov/study/NCT06581432","title":"Beamion PANTUMOR-1: A Phase II, Multicentre, Multicohort, Open-label Trial to Evaluate the Efficacy and Safety of Oral Zongertinib (BI 1810631) for the Treatment of Selected HER2-mutated or Overexpressed/Amplified Solid Tumours","has_exemption":false,"start_date":"2024-10-11","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06487221","publication_url":"https://clinicaltrials.gov/study/NCT06487221","title":"A Phase II Trial of Avutometinib in Combination With Defactinib in Metastatic Diffuse Gastric Cancer","has_exemption":false,"start_date":"2024-10-28","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Ryan H. Moy, MD, PhD","sponsor_slug":"ryan-h-moy-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655896","publication_url":"https://clinicaltrials.gov/study/NCT06655896","title":"A Phase II, Multi-part, Randomized, Open-label, Assessor-blinded, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants With Severe Refractory Diffuse Cutaneous Systemic Sclerosis","has_exemption":false,"start_date":"2024-10-29","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06399679","publication_url":"https://clinicaltrials.gov/study/NCT06399679","title":"Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium After Initial Control With Physostigmine (RIVA-AP): a Randomized, Placebo-controlled Trial","has_exemption":false,"start_date":"2024-11-04","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111313","publication_url":"https://clinicaltrials.gov/study/NCT06111313","title":"A Phase 2 Risk Adapted Parallel Randomized Trial of MRI-Guided Lattice Stereotactic Focal Radiotherapy of the Prostate With or Without Ultra-Short Term Androgen Deprivation Therapy-The Miami UAdapt Trial","has_exemption":false,"start_date":"2024-11-06","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06703476","publication_url":"https://clinicaltrials.gov/study/NCT06703476","title":"A Clinically Integrated Randomized Clinical Trial (RCT) of Modifications to Radical Cystectomy and Postoperative Care","has_exemption":false,"start_date":"2024-11-21","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06463457","publication_url":"https://clinicaltrials.gov/study/NCT06463457","title":"Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED)","has_exemption":false,"start_date":"2024-12-13","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Atish Choudhury, MD","sponsor_slug":"atish-choudhury-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06846541","publication_url":"https://clinicaltrials.gov/study/NCT06846541","title":"An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Safety, Efficacy, and Durability of Response to ESK-001","has_exemption":false,"start_date":"2025-01-08","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Alumis Inc","sponsor_slug":"alumis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06822738","publication_url":"https://clinicaltrials.gov/study/NCT06822738","title":"A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma","has_exemption":false,"start_date":"2025-02-11","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06829238","publication_url":"https://clinicaltrials.gov/study/NCT06829238","title":"Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use (MET-IH)","has_exemption":false,"start_date":"2025-04-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301177","publication_url":"https://clinicaltrials.gov/study/NCT07301177","title":"AtMS for Alleviating Posttraumatic Peripheral Neuropathic Pain (PTP-NP)","has_exemption":false,"start_date":"2025-04-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Veterans Medical Research Foundation","sponsor_slug":"veterans-medical-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06271590","publication_url":"https://clinicaltrials.gov/study/NCT06271590","title":"The MAGICAL SV Trial - A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Non Inferiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus-Coated Balloon in the Treatment of Small Vessels in Patients With Coronary Artery Disease.","has_exemption":false,"start_date":"2025-05-20","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Concept Medical Inc.","sponsor_slug":"concept-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07013110","publication_url":"https://clinicaltrials.gov/study/NCT07013110","title":"An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis - A Double-blind, Randomized, Placebo-controlled Clinical Trial","has_exemption":false,"start_date":"2025-06-18","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Prof Salvatore Albani","sponsor_slug":"prof-salvatore-albani","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07064759","publication_url":"https://clinicaltrials.gov/study/NCT07064759","title":"A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-07-22","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"4D Molecular Therapeutics","sponsor_slug":"4d-molecular-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07124910","publication_url":"https://clinicaltrials.gov/study/NCT07124910","title":"Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure Versus a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases","has_exemption":false,"start_date":"2025-08-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Woolfson Eye Institute","sponsor_slug":"woolfson-eye-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135167","publication_url":"https://clinicaltrials.gov/study/NCT07135167","title":"Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome","has_exemption":false,"start_date":"2025-08-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Woolfson Eye Institute","sponsor_slug":"woolfson-eye-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07047144","publication_url":"https://clinicaltrials.gov/study/NCT07047144","title":"A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA)","has_exemption":false,"start_date":"2025-09-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Scholar Rock, Inc.","sponsor_slug":"scholar-rock-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111520","publication_url":"https://clinicaltrials.gov/study/NCT07111520","title":"A Phase Ib/II, Multi-site, Open-label, Dose Finding Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT326 in Combination With BNT327 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2025-09-22","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222085","publication_url":"https://clinicaltrials.gov/study/NCT07222085","title":"Determining the Long-Term Stability of the Glide Control Strategy for Upper Limb Prostheses","has_exemption":false,"start_date":"2025-10-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Infinite Biomedical Technologies","sponsor_slug":"infinite-biomedical-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213804","publication_url":"https://clinicaltrials.gov/study/NCT07213804","title":"FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.","has_exemption":false,"start_date":"2025-10-22","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06793215","publication_url":"https://clinicaltrials.gov/study/NCT06793215","title":"A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Patients With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-10-24","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06659445","publication_url":"https://clinicaltrials.gov/study/NCT06659445","title":"A Phase 2 Multicenter, Randomized, Double-masked, Sham-controlled, Reference-arm Study to Evaluate Efficacy and Safety of ONL1204 in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2025-10-28","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"ONL Therapeutics","sponsor_slug":"onl-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216742","publication_url":"https://clinicaltrials.gov/study/NCT07216742","title":"A Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of a Human Menopausal Gonadotropin in the Development of Multiple Follicles, Pregnancy, and Cumulative Live Birth as Part of an Assisted Reproductive Technology (ART) Cycle.","has_exemption":false,"start_date":"2025-11-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Granata Bio Corporation","sponsor_slug":"granata-bio-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032792","publication_url":"https://clinicaltrials.gov/study/NCT07032792","title":"Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery","has_exemption":false,"start_date":"2025-11-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455319","publication_url":"https://clinicaltrials.gov/study/NCT06455319","title":"Precision Administration of Anti-thymocyte Globulin With or Without Verapamil in Adolescents and Young Adults With Type 1 Diabetes","has_exemption":false,"start_date":"2025-11-12","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07387978","publication_url":"https://clinicaltrials.gov/study/NCT07387978","title":"A Pilot Study to Describe the Effect of Photobiomodulation in Reducing the Severity and Incidence of Oral Mucositis in Oral Cancer Patients Undergoing Radiation Treatment","has_exemption":false,"start_date":"2025-11-26","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Peter MacCallum Cancer Centre, Australia","sponsor_slug":"peter-maccallum-cancer-centre-australia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07117669","publication_url":"https://clinicaltrials.gov/study/NCT07117669","title":"A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ENP-501 in Non-Peanut Allergic Participants and Participants With a Known Peanut Allergy","has_exemption":false,"start_date":"2025-12-16","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"N-Fold, LLC","sponsor_slug":"n-fold-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228247","publication_url":"https://clinicaltrials.gov/study/NCT07228247","title":"A Phase Ⅰ/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A251 in Participants With Advanced or Metastatic HER2-Expressing Solid Tumors","has_exemption":false,"start_date":"2025-12-16","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Hutchmed","sponsor_slug":"hutchmed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06575075","publication_url":"https://clinicaltrials.gov/study/NCT06575075","title":"A Double-blind, Placebo-controlled Study to Determine the Safety and Feasibility of Two Doses of Intravenous (2R, 6R)-Hydroxynorketamine (RR-HNK) in Adults With Obsessive-Compulsive Disorder","has_exemption":false,"start_date":"2026-01-23","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Carolyn Rodriguez","sponsor_slug":"carolyn-rodriguez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07091279","publication_url":"https://clinicaltrials.gov/study/NCT07091279","title":"Randomized Controlled Trial of Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism","has_exemption":false,"start_date":"2026-01-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Jeremy Veenstra-vanderweele","sponsor_slug":"jeremy-veenstra-vanderweele","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07344220","publication_url":"https://clinicaltrials.gov/study/NCT07344220","title":"Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate","has_exemption":false,"start_date":"2026-01-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Hoag Memorial Hospital Presbyterian","sponsor_slug":"hoag-memorial-hospital-presbyterian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424378","publication_url":"https://clinicaltrials.gov/study/NCT07424378","title":"Randomized Controlled Trial of Epoprostenol Versus Placebo in Addition to Standard Therapy for Severe Frostbite Injury","has_exemption":false,"start_date":"2026-02-28","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06434064","publication_url":"https://clinicaltrials.gov/study/NCT06434064","title":"A Pilot, Single-Arm, Phase II Trial of Tamoxifen Plus Pegylated Liposomal Doxorubicin in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2026-03-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227025","publication_url":"https://clinicaltrials.gov/study/NCT07227025","title":"A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2026-03-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07407933","publication_url":"https://clinicaltrials.gov/study/NCT07407933","title":"A Phase Ib/II, Multicenter, Open-Label Study to Evaluate Safety, Efficacy, and Pharmacokinetics of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-03-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"MediLink Therapeutics (Suzhou) Co., Ltd.","sponsor_slug":"medilink-therapeutics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07107334","publication_url":"https://clinicaltrials.gov/study/NCT07107334","title":"A Pilot Study to Estimate Early Clinical Efficacy Signals of a Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) Administration in Conjunction With Levonorgestrel Intrauterine Device (LNG-IUD) in Obese Patients With Endometrioid Intraepithelial Neoplasia","has_exemption":false,"start_date":"2026-04-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07133074","publication_url":"https://clinicaltrials.gov/study/NCT07133074","title":"Optimizing Antibiotic Selection in Hematologic Malignancy Patients With Reported Beta-lactam Allergy - Intervention","has_exemption":false,"start_date":"2026-04-20","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07326566","publication_url":"https://clinicaltrials.gov/study/NCT07326566","title":"A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII","has_exemption":false,"start_date":"2026-05-05","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Black Diamond Therapeutics, Inc.","sponsor_slug":"black-diamond-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07428746","publication_url":"https://clinicaltrials.gov/study/NCT07428746","title":"Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes","has_exemption":false,"start_date":"2026-05-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571135","publication_url":"https://clinicaltrials.gov/study/NCT07571135","title":"Letermovir Versus Valganciclovir for 90 Days in CMV Seropositive Kidney Transplant Recipients: Results of a Single-center Experience.","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Elisabeth Kincaide","sponsor_slug":"elisabeth-kincaide","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07673107","publication_url":"https://clinicaltrials.gov/study/NCT07673107","title":"A Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period to Evaluate the Efficacy and Safety of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Treatment of Upper Limb Essential Tremor in Adults","has_exemption":false,"start_date":"2026-06-18","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06210854","publication_url":"https://clinicaltrials.gov/study/NCT06210854","title":"Double-Blind Randomized Phase II Clinical Trial Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ <CIN2","has_exemption":false,"start_date":"2026-06-25","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06382649","publication_url":"https://clinicaltrials.gov/study/NCT06382649","title":"Rivastigmine for Antimuscarinic Delirium: a Randomized, Placebo-controlled Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07527299","publication_url":"https://clinicaltrials.gov/study/NCT07527299","title":"Assessment of the Safety and Effectiveness of the VARIPULSE™ Catheter System in the Treatment of Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein (With or Without Posterior Wall Isolation) and Superior Vena Cava Isolation: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-08-05","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07393555","publication_url":"https://clinicaltrials.gov/study/NCT07393555","title":"A Randomized Phase II Study of Sacituzumab Govitecan Alone, Ivonescimab Alone, or Sacituzumab Govitecan and Ivonescimab in Participants With Previously-Treated Actionable Genomic Alteration Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)","has_exemption":false,"start_date":"2026-08-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06458907","publication_url":"https://clinicaltrials.gov/study/NCT06458907","title":"A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"P+F Products + Features USA Inc.","sponsor_slug":"pf-products-features-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07650201","publication_url":"https://clinicaltrials.gov/study/NCT07650201","title":"A Prospective, Multicenter, Open-label, Single-arm Clinical Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) IOL for Correction of Aphakia Following Cataract Extraction","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Kowa Research Institute, Inc.","sponsor_slug":"kowa-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07748403","publication_url":"https://clinicaltrials.gov/study/NCT07748403","title":"A Phase 1/2 Clinical Study to Evaluate Safety, Tolerability, Biological Activity, and Initial Efficacy of Prime Editing (PM577a) for the Treatment of Wilson Disease (WD) in Adult and Adolescent Participants With at Least One Allele Harboring the p.H1069Q Mutation in ATP7B","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Prime Medicine, Inc.","sponsor_slug":"prime-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07769502","publication_url":"https://clinicaltrials.gov/study/NCT07769502","title":"A Phase 2, Open-Label, Master Protocol Study to Evaluate Safety and Efficacy of Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Pancreatobiliary Cancers (AndroMETa-118)","has_exemption":false,"start_date":"2026-09-22","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07552558","publication_url":"https://clinicaltrials.gov/study/NCT07552558","title":"Phase I/II Trial of Neoadjuvant Combination of Ficerafusp Alfa, Pembrolizumab, and SBRT for Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07570654","publication_url":"https://clinicaltrials.gov/study/NCT07570654","title":"A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"COMPASS Pathways","sponsor_slug":"compass-pathways","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07705607","publication_url":"https://clinicaltrials.gov/study/NCT07705607","title":"A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07581197","publication_url":"https://clinicaltrials.gov/study/NCT07581197","title":"A Phase 1/2 Dose Escalation Study to Evaluate the Safety and Efficacy of SR-02 Pancreatic Endocrine Cell Clusters Implanted in the Omentum of Adults With Type 1 Diabetes (SUGR)","has_exemption":false,"start_date":"2026-11-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Seraxis","sponsor_slug":"seraxis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07750574","publication_url":"https://clinicaltrials.gov/study/NCT07750574","title":"A Randomized, Phase 2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral Flonoltinib Maleate in Patients With JAK Inhibitor Treatment-Naïve or Resistant Myelofibrosis","has_exemption":false,"start_date":"2026-11-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Chengdu Zenitar Biomedical Technology Co., Ltd","sponsor_slug":"chengdu-zenitar-biomedical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03217110","publication_url":"https://clinicaltrials.gov/study/NCT03217110","title":"Cerebellar Transcranial Magnetic Stimulation and Cognitive Control","has_exemption":false,"start_date":"2017-11-30","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Krystal Parker, PhD","sponsor_slug":"krystal-parker-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04303117","publication_url":"https://clinicaltrials.gov/study/NCT04303117","title":"Phase I/II Study of PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma","has_exemption":false,"start_date":"2020-07-13","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04588077","publication_url":"https://clinicaltrials.gov/study/NCT04588077","title":"Comparison the Seroconversion Rate Between Two-dose and Three-dose Regimens of Heplisav B Among Patients With Cirrhosis, a Randomized-control Prospective Study.","has_exemption":false,"start_date":"2020-09-14","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Mercy Medical Center","sponsor_slug":"mercy-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04825522","publication_url":"https://clinicaltrials.gov/study/NCT04825522","title":"The Effect of Intrawound Vancomycin Powder in Spine Surgery: A Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2022-03-27","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Windsor-Essex Compassionate Care Community","sponsor_slug":"windsor-essex-compassionate-care-community","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05303519","publication_url":"https://clinicaltrials.gov/study/NCT05303519","title":"A Phase 3, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Participants With Isocitrate Dehydrogenase 1 (IDH1)-Mutant Glioma","has_exemption":false,"start_date":"2023-06-05","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Nuvation Bio, Inc.","sponsor_slug":"nuvation-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06082947","publication_url":"https://clinicaltrials.gov/study/NCT06082947","title":"αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) for Children and Young Adults With Hematologic Malignancies","has_exemption":false,"start_date":"2023-12-18","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06168942","publication_url":"https://clinicaltrials.gov/study/NCT06168942","title":"LAM202403: Laminar Left Atrial Appendage Elimination (LAAX) Pivotal IDE Study","has_exemption":false,"start_date":"2024-02-19","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06312813","publication_url":"https://clinicaltrials.gov/study/NCT06312813","title":"Pilot Studies Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea","has_exemption":false,"start_date":"2024-02-27","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Wright State University","sponsor_slug":"wright-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06030622","publication_url":"https://clinicaltrials.gov/study/NCT06030622","title":"Phase 2A Pilot Trial of Metformin, Digoxin, Simvastatin (C3) in Combination With Gemcitabine in Subjects With Recurrent / Refractory Metastatic Advanced Pancreatic Cancer","has_exemption":false,"start_date":"2024-04-17","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"State University of New York - Downstate Medical Center","sponsor_slug":"state-university-of-new-york-downstate-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06150417","publication_url":"https://clinicaltrials.gov/study/NCT06150417","title":"Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)","has_exemption":false,"start_date":"2024-07-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06282575","publication_url":"https://clinicaltrials.gov/study/NCT06282575","title":"An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer","has_exemption":false,"start_date":"2024-07-19","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06493370","publication_url":"https://clinicaltrials.gov/study/NCT06493370","title":"Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2025-01-16","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06216535","publication_url":"https://clinicaltrials.gov/study/NCT06216535","title":"Escitalopram in Asthma Patients With Frequent Exacerbation","has_exemption":false,"start_date":"2025-05-19","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07258446","publication_url":"https://clinicaltrials.gov/study/NCT07258446","title":"PRAME (Preferentially Expressed Antigen in Melanoma) Immunohistochemistry Guided Slow-Mohs Micrographic Surgery of Malignant Melanoma: A Pragmatic Clinical Trial","has_exemption":false,"start_date":"2025-10-24","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06419439","publication_url":"https://clinicaltrials.gov/study/NCT06419439","title":"Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression","has_exemption":false,"start_date":"2025-12-03","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226856","publication_url":"https://clinicaltrials.gov/study/NCT07226856","title":"Phase 2, Single-Arm Trial of BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-Paclitaxel in the First Line Setting of Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2025-12-12","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280169","publication_url":"https://clinicaltrials.gov/study/NCT07280169","title":"Identifying Non-Union Rates Using Carbo-fix Lateral Plate Devices and Standard Plate-Nail Construct in Distal Femur Fractures","has_exemption":false,"start_date":"2026-01-29","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07237048","publication_url":"https://clinicaltrials.gov/study/NCT07237048","title":"Effect of Oral Minocycline in Patients With Acute Stroke - a Randomized, Open Label, Prospective Trial","has_exemption":false,"start_date":"2026-02-02","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Joyce Chen","sponsor_slug":"joyce-chen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07199192","publication_url":"https://clinicaltrials.gov/study/NCT07199192","title":"A Multicenter, Randomized, Controlled Trial to Evaluate the Effectiveness and Safety of Systemic Corticosteroid Treatment for Hospitalized Patients With Severe Acute Respiratory Infection and Hypoxemia (STRIVE 003)","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07017829","publication_url":"https://clinicaltrials.gov/study/NCT07017829","title":"A Phase II Trial of GT103 in Combination With Pembrolizumab in STK11 Mutant Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06965504","publication_url":"https://clinicaltrials.gov/study/NCT06965504","title":"Initiation and Titration of Guideline Directed Medical Therapy in Heart Failure Cardiogenic Shock With Impella 5.5 for Cardiac Recovery: INTeGRATE","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Abiomed Inc.","sponsor_slug":"abiomed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07463521","publication_url":"https://clinicaltrials.gov/study/NCT07463521","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis","has_exemption":false,"start_date":"2026-05-27","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095894","publication_url":"https://clinicaltrials.gov/study/NCT07095894","title":"A Randomized Placebo-controlled Trial of Spectacles With Highly Aspherical Lenslet Target (H.A.L.T.) MAX Technology or 0.05% Atropine to Slow Progression of Myopia in Children","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07680946","publication_url":"https://clinicaltrials.gov/study/NCT07680946","title":"Evaluating Safety and Efficacy of Ublituximab in Participants With Schizophrenia","has_exemption":false,"start_date":"2026-07-03","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"TG Therapeutics, Inc.","sponsor_slug":"tg-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07535489","publication_url":"https://clinicaltrials.gov/study/NCT07535489","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of IPG11406 Tablets in Adult Patients With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2026-07-07","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Nanjing Immunophage Biotech Co., Ltd","sponsor_slug":"nanjing-immunophage-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228195","publication_url":"https://clinicaltrials.gov/study/NCT07228195","title":"SGLT2i Therapy in Islet Transplantation (SIT)","has_exemption":false,"start_date":"2026-07-21","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07686068","publication_url":"https://clinicaltrials.gov/study/NCT07686068","title":"Phase 1/2a Open-Label Clinical Trial Evaluating VBC106, an FRα- and MSLN-Directed Bispecific Antibody Drug Conjugate, in Participants With Advanced Malignant Solid Tumors","has_exemption":false,"start_date":"2026-08-18","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"VelaVigo Bio Inc","sponsor_slug":"velavigo-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07741890","publication_url":"https://clinicaltrials.gov/study/NCT07741890","title":"aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"The Christ Hospital","sponsor_slug":"the-christ-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07349693","publication_url":"https://clinicaltrials.gov/study/NCT07349693","title":"A Randomized Trial to Assess the Efficacy and Safety of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma","has_exemption":false,"start_date":"2026-11-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Everfront Biotech Co., Ltd.","sponsor_slug":"everfront-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03787290","publication_url":"https://clinicaltrials.gov/study/NCT03787290","title":"Examining Immune-Based Mechanisms of Action for Mild-Intensity Whole Body Hyperthermia (WBH) in the Treatment of Major Depressive Disorder","has_exemption":false,"start_date":"2026-12-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07274787","publication_url":"https://clinicaltrials.gov/study/NCT07274787","title":"An Open Label, Prospective, Pilot Study To Evaluate The Safety And Effectiveness Of The NaviFUS System In Conjunction With A Standard Treatment Regimen Of Bevacizumab (BEV) In Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2026-12-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07734077","publication_url":"https://clinicaltrials.gov/study/NCT07734077","title":"Phase Ib/II Study Of Revumenib As Monotherapy Or In Combination With Jak Inhibitors In Patients With Myelofibrosis","has_exemption":false,"start_date":"2026-12-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"John Mascarenhas","sponsor_slug":"john-mascarenhas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06634589","publication_url":"https://clinicaltrials.gov/study/NCT06634589","title":"A Phase 1b/2, Open-Label, Master Protocol Study of BTK-Degrader BGB-16673 in Combination With Other Agents in Patients With Relapsed or Refractory B-Cell Malignancies","has_exemption":false,"start_date":"2024-11-27","completion_date":"2028-12-02","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05205174","publication_url":"https://clinicaltrials.gov/study/NCT05205174","title":"Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury","has_exemption":false,"start_date":"2025-04-03","completion_date":"2028-12-03","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06130553","publication_url":"https://clinicaltrials.gov/study/NCT06130553","title":"PRIMROSE: A Modular Phase I/IIa, Multi-centre, Dose Escalation, and Expansion Study of AZD3470, a MTA Cooperative PRMT5 Inhibitor, as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced/Metastatic Solid Tumors That Are MTAP Deficient","has_exemption":false,"start_date":"2024-01-18","completion_date":"2028-12-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07134088","publication_url":"https://clinicaltrials.gov/study/NCT07134088","title":"A Phase 1b/2 Study to Investigate the Safety, Efficacy and Pharmacokinetics of Administration of Subcutaneous (SC) Blinatumomab in Pediatric Participants With Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+) B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)","has_exemption":false,"start_date":"2025-12-08","completion_date":"2028-12-05","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540988","publication_url":"https://clinicaltrials.gov/study/NCT07540988","title":"A Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy and Safety of Nerandomilast Over at Least 52 Weeks in Patients With Fibrosing Interstitial Lung Disease at Risk for Disease Progression (FIBRONEER-ACT)","has_exemption":false,"start_date":"2026-08-28","completion_date":"2028-12-05","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07438496","publication_url":"https://clinicaltrials.gov/study/NCT07438496","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2026-03-05","completion_date":"2028-12-06","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07759128","publication_url":"https://clinicaltrials.gov/study/NCT07759128","title":"A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Trial to Compare the Efficacy and Safety of Fixed Doses of SEP-363856 to Placebo in the Treatment of Adults With Generalized Anxiety Disorder","has_exemption":false,"start_date":"2026-07-28","completion_date":"2028-12-06","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07569081","publication_url":"https://clinicaltrials.gov/study/NCT07569081","title":"A Randomized Phase 2/3, Double-blind, Placebo Controlled Adaptive Study Evaluating the Efficacy and Safety of Momelotinib in Participants With VEXAS Syndrome","has_exemption":false,"start_date":"2026-08-05","completion_date":"2028-12-06","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218029","publication_url":"https://clinicaltrials.gov/study/NCT07218029","title":"An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038)","has_exemption":false,"start_date":"2021-05-12","completion_date":"2028-12-07","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596694","publication_url":"https://clinicaltrials.gov/study/NCT06596694","title":"A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers","has_exemption":false,"start_date":"2024-11-03","completion_date":"2028-12-07","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07625306","publication_url":"https://clinicaltrials.gov/study/NCT07625306","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Study Evaluating the Efficacy, Safety, Tolerability, and Coronary Plaque Effects of Early Pelacarsen (TQJ230) Initiation in Patients in the US With Elevated Lp(a) and Recent Acute Coronary Syndrome","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-12-07","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06784752","publication_url":"https://clinicaltrials.gov/study/NCT06784752","title":"A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients Newly Diagnosed With Grade 1 and Grade 2 (Ki-67 <10%) Advanced GEP-NET With High Disease Burden (NETTER-3)","has_exemption":false,"start_date":"2025-05-30","completion_date":"2028-12-08","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07559513","publication_url":"https://clinicaltrials.gov/study/NCT07559513","title":"Phase 3 Evaluation of the Safety, Pharmacokinetics, and Efficacy of Garetosmab (Anti-Activin A Monoclonal Antibody) in Children and Adolescents With Fibrodysplasia Ossificans Progressiva","has_exemption":false,"start_date":"2026-07-30","completion_date":"2028-12-10","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06093126","publication_url":"https://clinicaltrials.gov/study/NCT06093126","title":"Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial","has_exemption":false,"start_date":"2023-12-11","completion_date":"2028-12-11","has_results":false,"results_due":false,"sponsor_name":"Nova Scotia Health Authority","sponsor_slug":"nova-scotia-health-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282665","publication_url":"https://clinicaltrials.gov/study/NCT07282665","title":"A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER","has_exemption":false,"start_date":"2025-12-10","completion_date":"2028-12-11","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07646821","publication_url":"https://clinicaltrials.gov/study/NCT07646821","title":"A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in Newly Diagnosed MDS/AML (≥ 10% Blasts) With TP53 Mutations","has_exemption":false,"start_date":"2026-11-27","completion_date":"2028-12-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07258511","publication_url":"https://clinicaltrials.gov/study/NCT07258511","title":"A Phase 3 Randomized Study Comparing JNJ-79635322 and an Anti-BCMAxCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti CD38 Antibody","has_exemption":false,"start_date":"2026-02-04","completion_date":"2028-12-12","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400107","publication_url":"https://clinicaltrials.gov/study/NCT07400107","title":"Efficacy and Safety of NNC0487-0111 s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Overweight or Obesity, and Type 2 Diabetes (AMAZE 8)","has_exemption":false,"start_date":"2026-05-20","completion_date":"2028-12-12","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06952660","publication_url":"https://clinicaltrials.gov/study/NCT06952660","title":"A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER","has_exemption":false,"start_date":"2025-05-07","completion_date":"2028-12-13","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07386002","publication_url":"https://clinicaltrials.gov/study/NCT07386002","title":"A Phase II, Open-Label, Multicenter Study With a Safety Run-In to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of MT027 Administrated Intracerebroventricularly in Patients With Recurrent or Progressive Glioblastoma (WHO Grade 4)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-12-13","has_results":false,"results_due":false,"sponsor_name":"T-MAXIMUM Pharmaceutical Inc","sponsor_slug":"t-maximum-pharmaceutical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513181","publication_url":"https://clinicaltrials.gov/study/NCT07513181","title":"A Phase 2b, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Clinical Study to Evaluate the Efficacy and Safety of ATH-063 Induction Therapy in Patients With Biologic Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-12-14","has_results":false,"results_due":false,"sponsor_name":"Athos Therapeutics Inc","sponsor_slug":"athos-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662786","publication_url":"https://clinicaltrials.gov/study/NCT06662786","title":"A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer","has_exemption":false,"start_date":"2024-10-18","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07100080","publication_url":"https://clinicaltrials.gov/study/NCT07100080","title":"IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy","has_exemption":false,"start_date":"2025-11-05","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281716","publication_url":"https://clinicaltrials.gov/study/NCT07281716","title":"A Phase 1b/2 Study of Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Dan Feng","sponsor_slug":"dan-feng","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293754","publication_url":"https://clinicaltrials.gov/study/NCT07293754","title":"A Phase 1/2 Trial of RPTR-1-201, a T Cell Receptor Bispecific Therapy, in Advanced Solid Tumors","has_exemption":false,"start_date":"2025-12-12","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Repertoire Immune Medicines","sponsor_slug":"repertoire-immune-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282587","publication_url":"https://clinicaltrials.gov/study/NCT07282587","title":"A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma","has_exemption":false,"start_date":"2026-01-02","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06572423","publication_url":"https://clinicaltrials.gov/study/NCT06572423","title":"Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)","has_exemption":false,"start_date":"2024-10-25","completion_date":"2028-12-16","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05790213","publication_url":"https://clinicaltrials.gov/study/NCT05790213","title":"Phase II Trial of Focal Prostate Ablation Combined With Androgen Deprivation Therapy for Prostate Cancer Treatment","has_exemption":false,"start_date":"2025-05-05","completion_date":"2028-12-18","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07405476","publication_url":"https://clinicaltrials.gov/study/NCT07405476","title":"A Phase II Clinical Trial of Neoadjuvant Zanidatamab for HER2+ Localized Colorectal Cancer","has_exemption":false,"start_date":"2026-04-07","completion_date":"2028-12-18","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07634601","publication_url":"https://clinicaltrials.gov/study/NCT07634601","title":"A Phase II Study of Elacestrant, an Oral Selective Estrogen Receptor Degrader (SERD) Combined With Everolimus in Patients With Recurrent or Metastatic ER-Positive (ER+) Endometrial Cancer (ELAVERA)","has_exemption":false,"start_date":"2026-12-18","completion_date":"2028-12-18","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05334368","publication_url":"https://clinicaltrials.gov/study/NCT05334368","title":"A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES)","has_exemption":false,"start_date":"2022-09-06","completion_date":"2028-12-19","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07405801","publication_url":"https://clinicaltrials.gov/study/NCT07405801","title":"A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Patients With Endocrine- Resistant Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer With Chromosome 8P Loss and Without a PIK3CA Mutation","has_exemption":false,"start_date":"2026-04-07","completion_date":"2028-12-19","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05723926","publication_url":"https://clinicaltrials.gov/study/NCT05723926","title":"Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation","has_exemption":false,"start_date":"2026-01-09","completion_date":"2028-12-20","has_results":false,"results_due":false,"sponsor_name":"Javelin Medical","sponsor_slug":"javelin-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858501","publication_url":"https://clinicaltrials.gov/study/NCT06858501","title":"Concordance in Response Assessment Incorporating Meta-Iodobenzylguanidine (123I-MIBG) and Meta-[18F]Fluorobenzylguanidine (18F-MFBG, IND#146379, NSC#853868) Imaging in Neuroblastoma","has_exemption":false,"start_date":"2026-09-22","completion_date":"2028-12-20","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04468659","publication_url":"https://clinicaltrials.gov/study/NCT04468659","title":"AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study With an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (A3 Trial)","has_exemption":false,"start_date":"2020-07-14","completion_date":"2028-12-21","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06191315","publication_url":"https://clinicaltrials.gov/study/NCT06191315","title":"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze","has_exemption":false,"start_date":"2024-01-03","completion_date":"2028-12-21","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07053423","publication_url":"https://clinicaltrials.gov/study/NCT07053423","title":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilumab on Airway Inflammation Through Assessments of Mucus Plugging and Other Lung Imaging Parameters in Patients With Chronic Obstructive Pulmonary Disease.","has_exemption":false,"start_date":"2025-09-22","completion_date":"2028-12-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205718","publication_url":"https://clinicaltrials.gov/study/NCT07205718","title":"An Open-label, Dose Escalation and Expansion, Phase 1/2 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TAK- 188, an Anti-CCR8 Antibody-Drug- Conjugate, as a Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-11-19","completion_date":"2028-12-26","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07748624","publication_url":"https://clinicaltrials.gov/study/NCT07748624","title":"VEX-AR: Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase 2 Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome, Followed by an Open-Label Extension Period","has_exemption":false,"start_date":"2026-10-30","completion_date":"2028-12-26","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01174121","publication_url":"https://clinicaltrials.gov/study/NCT01174121","title":"A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphodepleting Regimen in Metastatic Cancers Plus the Administration of Pembrolizumab","has_exemption":false,"start_date":"2010-08-26","completion_date":"2028-12-27","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07220083","publication_url":"https://clinicaltrials.gov/study/NCT07220083","title":"A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants","has_exemption":false,"start_date":"2026-02-16","completion_date":"2028-12-27","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07716098","publication_url":"https://clinicaltrials.gov/study/NCT07716098","title":"A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression","has_exemption":false,"start_date":"2026-07-27","completion_date":"2028-12-27","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05248659","publication_url":"https://clinicaltrials.gov/study/NCT05248659","title":"A Phase 2/3, Multicenter, Open-label Trial to Evaluate the Long-term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.","has_exemption":false,"start_date":"2022-04-05","completion_date":"2028-12-28","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07481981","publication_url":"https://clinicaltrials.gov/study/NCT07481981","title":"A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2026-07-21","completion_date":"2028-12-28","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07728097","publication_url":"https://clinicaltrials.gov/study/NCT07728097","title":"A Phase 3b/4, Interventional, Prospective, Multicenter, Open-Label Study Evaluating the Effectiveness of a Gradual Titration Regimen to Optimize CBD-OS as Add-On Therapy in Adults With Lennox-Gastaut Syndrome","has_exemption":false,"start_date":"2026-11-18","completion_date":"2028-12-28","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05035836","publication_url":"https://clinicaltrials.gov/study/NCT05035836","title":"A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)","has_exemption":false,"start_date":"2021-11-16","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05421663","publication_url":"https://clinicaltrials.gov/study/NCT05421663","title":"A Phase 1b/2, Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants With B-cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-08-12","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06396039","publication_url":"https://clinicaltrials.gov/study/NCT06396039","title":"A Phase 4, Multicenter, Single-arm, Open-label Study to Evaluate the Effectiveness and Safety of Oral Ozanimod for Relapsing Multiple Sclerosis (RMS) in Chinese Participants","has_exemption":false,"start_date":"2024-05-15","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06855771","publication_url":"https://clinicaltrials.gov/study/NCT06855771","title":"A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of Navlimetostat (BMS-986504) Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies","has_exemption":false,"start_date":"2025-09-09","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204275","publication_url":"https://clinicaltrials.gov/study/NCT07204275","title":"A Phase 2b/3 Adaptive, Randomized, Active-controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy","has_exemption":false,"start_date":"2025-09-30","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284849","publication_url":"https://clinicaltrials.gov/study/NCT07284849","title":"A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer","has_exemption":false,"start_date":"2026-03-05","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566195","publication_url":"https://clinicaltrials.gov/study/NCT07566195","title":"A Phase III, Multicentre, Open-Label, Chronic Dosing, Extension Study to Evaluate the Long-term Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations (ROMEO)","has_exemption":false,"start_date":"2026-05-05","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03801434","publication_url":"https://clinicaltrials.gov/study/NCT03801434","title":"Phase 2 Study of Ruxolitinib in Idiopathic Hypereosinophilic Syndrome and Primary Eosinophilic Disorders","has_exemption":false,"start_date":"2019-11-15","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"William Shomali","sponsor_slug":"william-shomali","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05183152","publication_url":"https://clinicaltrials.gov/study/NCT05183152","title":"Non-invasive Brain-computer Interfaces for Control of Assistive Devices","has_exemption":false,"start_date":"2021-06-16","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05573308","publication_url":"https://clinicaltrials.gov/study/NCT05573308","title":"Optimizing Clear Aligners Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms","has_exemption":false,"start_date":"2022-10-17","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04855630","publication_url":"https://clinicaltrials.gov/study/NCT04855630","title":"Combating Alzheimer's Through Sleep and Exercise (CASE)","has_exemption":false,"start_date":"2023-03-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05655182","publication_url":"https://clinicaltrials.gov/study/NCT05655182","title":"A Phase 1/2a Trial of the Safety, Tolerability and Immunogenicity of PIV5-vectored RSV Vaccine (BLB-201) in RSV Seronegative and Seropositive Infants and Children","has_exemption":false,"start_date":"2023-03-09","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Blue Lake Biotechnology Inc.","sponsor_slug":"blue-lake-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05897086","publication_url":"https://clinicaltrials.gov/study/NCT05897086","title":"Nerve Repair Using Hydrophilic Polymers to Improve Tactile and Erogenous Neophallus Sensation","has_exemption":false,"start_date":"2023-08-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06483347","publication_url":"https://clinicaltrials.gov/study/NCT06483347","title":"Intra-tumor Delivery of Double Checkpoint Inhibitors, Chemodrug, and/or Bevacizumab Therapy as First Line for Inoperable Lung Cancer","has_exemption":false,"start_date":"2024-04-04","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","sponsor_slug":"second-affiliated-hospital-of-guangzhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492421","publication_url":"https://clinicaltrials.gov/study/NCT06492421","title":"Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Stage I-IIIA Non-Small Cell Lung Cancers Amenable for Surgical Resection","has_exemption":false,"start_date":"2024-07-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","sponsor_slug":"second-affiliated-hospital-of-guangzhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492408","publication_url":"https://clinicaltrials.gov/study/NCT06492408","title":"Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Hepatocellular Carcinoma (HCC) Amenable for Surgical Resection","has_exemption":false,"start_date":"2024-07-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","sponsor_slug":"second-affiliated-hospital-of-guangzhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06644833","publication_url":"https://clinicaltrials.gov/study/NCT06644833","title":"Effectiveness of Transcranial Magnetic Stimulation (TMS) Versus Treatment as Usual for First-Episode Depression in Adult Patients. An Open-Label Randomised Controlled Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Sultan Qaboos University","sponsor_slug":"sultan-qaboos-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526935","publication_url":"https://clinicaltrials.gov/study/NCT07526935","title":"Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator in the Management of Refractory Gastroparesis- A Randomized Single Blinded Control Trial","has_exemption":false,"start_date":"2025-03-19","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06271707","publication_url":"https://clinicaltrials.gov/study/NCT06271707","title":"Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study","has_exemption":false,"start_date":"2025-05-19","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07109726","publication_url":"https://clinicaltrials.gov/study/NCT07109726","title":"A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations","has_exemption":false,"start_date":"2025-09-23","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Terremoto Biosciences Inc.","sponsor_slug":"terremoto-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07122713","publication_url":"https://clinicaltrials.gov/study/NCT07122713","title":"Multi-institutional Prospective Pilot Study of Definitive Breast Radiation Therapy for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery","has_exemption":false,"start_date":"2025-12-08","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Alexander Stessin","sponsor_slug":"alexander-stessin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04993027","publication_url":"https://clinicaltrials.gov/study/NCT04993027","title":"Topical Vancomycin for Infection Prophylaxis in Total Hip and Knee Arthroplasty","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Alberta Hip and Knee Clinic","sponsor_slug":"alberta-hip-and-knee-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07179380","publication_url":"https://clinicaltrials.gov/study/NCT07179380","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease","has_exemption":false,"start_date":"2026-01-07","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07162363","publication_url":"https://clinicaltrials.gov/study/NCT07162363","title":"Synergistic Intervention of Minimally Invasive Surgery and Deferoxamine in Intracerebral Hemorrhage (SMAD)","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07442461","publication_url":"https://clinicaltrials.gov/study/NCT07442461","title":"Effects of Visual Impairment on Neurophysiological Responses and the Feasibility and Impact of Multimodal Virtual Assistance for Instrumental Activities of Daily Living in Low Vision Populations","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07573462","publication_url":"https://clinicaltrials.gov/study/NCT07573462","title":"A PHASE 3, RANDOMIZED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS","has_exemption":false,"start_date":"2026-05-04","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07621718","publication_url":"https://clinicaltrials.gov/study/NCT07621718","title":"RASolute 305: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (Modified FOLFIRINOX or Gemcitabine Plus Nab-Paclitaxel) With or Without Zoldonrasib (RMC-9805) as First-line Treatment in Patients With Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-05-22","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07664150","publication_url":"https://clinicaltrials.gov/study/NCT07664150","title":"A Phase I/II, Open-Label, Non-Randomized, Multi-Centre First-in-Human Study of CAN016 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-06-18","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Canwell Biotech Limited","sponsor_slug":"canwell-biotech-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07514858","publication_url":"https://clinicaltrials.gov/study/NCT07514858","title":"Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Trial of Lu AF28996 in Adults With Parkinson's Disease Experiencing Motor Fluctuations","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07640737","publication_url":"https://clinicaltrials.gov/study/NCT07640737","title":"A Phase 2 Study Evaluating the Efficacy and Safety Agent AUR103 Calcium in Patients With Advanced, Well or Moderately Differentiated Neuroendocrine Tumours (BHARAT-3)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Aurigene Discovery Technologies Limited","sponsor_slug":"aurigene-discovery-technologies-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01269190","publication_url":"https://clinicaltrials.gov/study/NCT01269190","title":"Wide-Field and High Resolution In Vivo Imaging of Oral Neoplasia Using Topical Fluorescent Dyes: A Feasibility Study","has_exemption":false,"start_date":"2010-12-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01419561","publication_url":"https://clinicaltrials.gov/study/NCT01419561","title":"Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)","has_exemption":false,"start_date":"2011-09-08","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01570998","publication_url":"https://clinicaltrials.gov/study/NCT01570998","title":"Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery","has_exemption":false,"start_date":"2012-05-18","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02201589","publication_url":"https://clinicaltrials.gov/study/NCT02201589","title":"Proposed Single Center Investigational Device Exemption: Feasibility of Endovascular Repair Of Ascending Aortic Pathologies","has_exemption":false,"start_date":"2013-11-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Rodney A. White, M.D.","sponsor_slug":"rodney-a-white-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02000089","publication_url":"https://clinicaltrials.gov/study/NCT02000089","title":"The Cancer of the Pancreas Screening-5 CAPS5)Study","has_exemption":false,"start_date":"2014-01-06","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02266719","publication_url":"https://clinicaltrials.gov/study/NCT02266719","title":"Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex Aortic Aneurysms Using Fenestrated and Branched Devices","has_exemption":false,"start_date":"2014-12-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Carlos Timaran","sponsor_slug":"carlos-timaran","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02329652","publication_url":"https://clinicaltrials.gov/study/NCT02329652","title":"Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury","has_exemption":false,"start_date":"2014-12-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Anne Bryden","sponsor_slug":"anne-bryden","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02272049","publication_url":"https://clinicaltrials.gov/study/NCT02272049","title":"Use of Hyperpolarized 129 Xe MR Lung Imaging in Children and Adults","has_exemption":false,"start_date":"2014-12-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02346747","publication_url":"https://clinicaltrials.gov/study/NCT02346747","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy","has_exemption":false,"start_date":"2015-02-28","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Gradalis, Inc.","sponsor_slug":"gradalis-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02468024","publication_url":"https://clinicaltrials.gov/study/NCT02468024","title":"JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial","has_exemption":false,"start_date":"2015-07-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02861898","publication_url":"https://clinicaltrials.gov/study/NCT02861898","title":"Phase I/II Trial of Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2016-06-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02721732","publication_url":"https://clinicaltrials.gov/study/NCT02721732","title":"Phase II Study for the Evaluation of Efficacy of Pembrolizumab (MK-3475) in Patients With Rare Tumors","has_exemption":false,"start_date":"2016-08-15","completion_date":"2028-12-31","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02890485","publication_url":"https://clinicaltrials.gov/study/NCT02890485","title":"The Effects of Dry Needling on Patients With Knee Pain","has_exemption":false,"start_date":"2016-08-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02784210","publication_url":"https://clinicaltrials.gov/study/NCT02784210","title":"The Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques: An Investigator-Blinded Study","has_exemption":false,"start_date":"2016-10-05","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","sponsor_slug":"national-institute-of-neurological-disorders-and-stroke-ninds","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03013998","publication_url":"https://clinicaltrials.gov/study/NCT03013998","title":"A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)","has_exemption":false,"start_date":"2016-11-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Beat AML, LLC","sponsor_slug":"beat-aml-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03096197","publication_url":"https://clinicaltrials.gov/study/NCT03096197","title":"Exoskeleton and Spinal Cord Stimulation for SCI","has_exemption":false,"start_date":"2017-03-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03215719","publication_url":"https://clinicaltrials.gov/study/NCT03215719","title":"Adaptive De-escalation of Radiation Therapy Dose in HPV-Positive Oropharyngeal Carcinoma (ART) Demonstrating Favorable Mid-Treatment Response","has_exemption":false,"start_date":"2017-10-18","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03317158","publication_url":"https://clinicaltrials.gov/study/NCT03317158","title":"PhAse 1/2 StuDy of Modern ImmunotherApy in BCG-Unresponsive, BCG-RelaPsing, and High-Risk BCG-Naive Non-muscle Invasive UroThelial Carcinoma of the BLADDER","has_exemption":false,"start_date":"2017-11-21","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Noah Hahn, M.D.","sponsor_slug":"noah-hahn-md","status":"ongoing","is_pact":false,"days_late":null}]}